"10.1371_journal.pone.0147947","plos one","2016-04-01T00:00:00Z","Lucie Hopes; Guillaume Grolez; Caroline Moreau; Renaud Lopes; Gilles Ryckewaert; Nicolas Carrière; Florent Auger; Charlotte Laloux; Maud Petrault; Jean-Christophe Devedjian; Regis Bordet; Luc Defebvre; Patrice Jissendi; Christine Delmaire; David Devos","Department of Movement Disorders and Neurology, Lille University Hospital, Lille, France; INSERM U1171, Faculty of Medicine, Lille University, Lille, France; Department of Neuroradiology, Lille University Hospital, Lille, France; Department of Small Animal Imaging Unit, Lille University, Lille, France; Department of Medical Pharmacology, Lille University, Lille, France","Conceived and designed the experiments: DD PJ LD RB CM LH GG RL CD FA CL MP JCD GR NC. Performed the experiments: LH GG GR PJ RL FA CL MP. Analyzed the data: DD LH GG GR FA CL MP. Contributed reagents/materials/analysis tools: RL CD PJ RB DD FA CL MP JCD. Wrote the paper: LH DD RL.","The authors have the following interests: Lucie Hopes, Guillaume Grolez, Renaud Lopes, Christine Demaire, Florent Auger, Charlotte Laloux, Maud Petrault, Jean-Christophe Devedjian, Gilles Ryckewaert and Patrice Jissendi have no disclosures to report. Caroline Moreau has served on the Scientific Advisory Board for Aguettant and Abbvie. Kathy Dujardin has served on the Scientific Advisory Board for Novartis and received a grant from the MJ Fox Foundation for Parkinsons research. Régis Bordet receives funding from the French Ministry of Research. He has received various honoraria from pharmaceutical companies (Novartis, Lundbeck, Boehringer Ingelheim) for consultancy and lectures at symposia. Luc Defebvre has served on the Scientific Advisory Board for Novartis, Aguettant, and Abbvie and has received various honoraria from pharmaceutical companies (Abbvie) for consultancy and lectures on Parkinson’s disease at symposia. David Devos served on the Scientific Advisory Board for Novartis and Aguettant. He has received research funding from the French Ministry of Health and the ARSLA charity, together with consultancy fees and speakers fees from pharmaceutical companies (Novartis, Lundbeck, Boehringer Ingelheim, Teva, ABBVIE, Aguettant, Medtronic). There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","04","Lucie Hopes","LH",15,TRUE,15,8,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
